SCHEMBL29638530

SCHEMBL29638530

Cc1ccc2c(Nc3cc(F)c(F)cc3F)nccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 4/20 0.44
HDAC1 Q13547 4/20 0.44
HDAC6 Q9UBN7 4/20 0.44
GRM4 Q14833 1/20 0.40
HTR1A P08908 2/20 0.36
ADRA1D P25100 2/20 0.36
ADRA1A P35348 2/20 0.36
ADRA1B P35368 2/20 0.36
CDK4 P11802 2/20 0.36
CDK2 P24941 2/20 0.36
LMNA P02545 1/20 0.36
KDR P35968 2/20 0.35
RAF1 P04049 1/20 0.35
BRAF P15056 1/20 0.35
WNT3A P56704 2/20 0.35
CCNE1 P24864 1/20 0.35
TNF P01375 2/20 0.34
SYK P43405 1/20 0.34
RET P07949 1/20 0.34
KIF5B P33176 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638531 0.90 HDAC3 (0.53) HDAC3HDAC1HDAC6GRM4HTR1A
SCHEMBL29638579 0.82 TRPA1 (0.44) HDAC3HDAC1HDAC6GRM4HTR1A
SCHEMBL29638511 0.82 DYRK1A (0.47) HDAC3HDAC1HDAC6KDRRAF1
SCHEMBL29638713 0.80 RAPGEF4 (0.41) HDAC3HDAC1HDAC6HTR1AADRA1D
SCHEMBL29638608 0.80 HDAC3 (0.46) HDAC3HDAC1HDAC6KDRRAF1
SCHEMBL15108911 0.77 WNT3A (0.40) HTR1AADRA1DADRA1AADRA1BLMNA
SCHEMBL24399714 0.75 EGFR (0.36) HDAC3HDAC1HDAC6LMNAKDR
SCHEMBL29638638 0.75 EGFR (0.36) HDAC3HDAC1HDAC6LMNAKDR
SCHEMBL8297790 0.75 WNT3A (0.41) HTR1AADRA1DADRA1AADRA1BLMNA
SCHEMBL13686770 0.75 MAPK1 (0.56) TNFLRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed